Target Name: FKBP14
NCBI ID: G55033
Review Report on FKBP14 Target / Biomarker Content of Review Report on FKBP14 Target / Biomarker
FKBP14
Other Name(s): FKBP prolyl isomerase 14, transcript variant 1 | FKBP14 variant 1 | Rotamase | FK506 binding protein 14 (FKBP14) | FK506-binding protein 14 | rotamase | PPIase FKBP14 | FKBP-22 | FKBP22 | 22 kDa FK506-binding protein | IPBP12 | FKB14_HUMAN | FKBP-14 | Peptidyl-prolyl cis-trans isomerase FKBP14 | EDSKMH | 22 kDa FKBP | FKBP prolyl isomerase 14 | FK506 binding protein 14, 22 kDa | EDSKSCL2

FKBP14 Gene: Potential Drug Target and Biomarker

FKBP14, also known as FKBP14 gene, is a protein that is located on chromosome 16 of the human genome. It is a key regulator of the protein FKBP14, which is a well-known protein that is involved in the regulation of various cellular processes. FKBP14 has been identified as a potential drug target and has been shown to be involved in a variety of biological processes, including the regulation of cell growth, apoptosis, and inflammation.

The FKBP14 gene was first identified in the late 1990s as a gene that was expressed in a variety of tissues and was shown to be involved in the regulation of various cellular processes. The FKBP14 gene is located on chromosome 16 and has been shown to encode a protein that is composed of 1,964 amino acids.

The FKBP14 protein is a key regulator of the FKBP14 protein, which is a well-known protein that is involved in the regulation of various cellular processes. The FKBP14 protein is composed of 1,964 amino acids and is located on chromosome 16. It is expressed in a variety of tissues and is shown to play a role in the regulation of cell growth, apoptosis, and inflammation.

One of the most promising aspects of the FKBP14 gene is its potential as a drug target. The FKBP14 protein is involved in a variety of cellular processes, including the regulation of cell growth, apoptosis, and inflammation. As a result, the FKBP14 gene has been shown to be a potential drug target.

In addition to its potential as a drug target, the FKBP14 gene is also a potential biomarker. The FKBP14 gene is expressed in a variety of tissues, including the brain, heart, and liver, and is shown to be involved in the regulation of various cellular processes. As a result, the FKBP14 gene has been shown to be a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

The FKBP14 gene has also been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die when they are no longer needed. The FKBP14 protein is shown to play a role in the regulation of cell apoptosis, and it is thought to do so by regulating the production of proteins that are involved in cell death.

In addition to its potential as a drug target and biomarker, the FKBP14 gene is also of interest to researchers as a potential research tool. The FKBP14 gene is well-studied and is known to be involved in the regulation of various cellular processes. As a result, the FKBP14 gene has been used as a tool for studying the regulation of cellular processes, including the regulation of cell growth, apoptosis, and inflammation.

In conclusion, FKBP14 is a gene that has been identified as a potential drug target and biomarker. It is located on chromosome 16 and encodes a protein that is involved in the regulation of various cellular processes. The FKBP14 protein is composed of 1,964 amino acids and is expressed in a variety of tissues. Its potential as a drug target and biomarker is based on its involvement in the regulation of cell growth, apoptosis, and inflammation. Furthermore, the FKBP14 gene is also a potential research tool and has been used as such to study the regulation of cellular processes.

Protein Name: FKBP Prolyl Isomerase 14

Functions: PPIase which accelerates the folding of proteins during protein synthesis. Has a preference for substrates containing 4-hydroxylproline modifications, including type III collagen. May also target type VI and type X collagens

The "FKBP14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FKBP14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FKBP15 | FKBP1A | FKBP1A-SDCBP2 | FKBP1B | FKBP1C | FKBP2 | FKBP3 | FKBP4 | FKBP5 | FKBP6 | FKBP7 | FKBP8 | FKBP9 | FKBP9P1 | FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A | FNDC3B | FNDC4